Polymorphisms in the non-muscle heavy chain 9 (MYH9) and apolipoprotein L1 (APOL1) genes are known to be associated with the risk of CKD development, particularly in African-descendent populations [39]. This evidence concerns the gene APOL1 and chronic kidney disease.